Global Pharmaceuticals & Biotech Profitable Climbers

Pharma Mar

Market Cap: €1.4b

A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally.

TG Therapeutics

Market Cap: US$4.3b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Camurus

Market Cap: SEK 41.4b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

Oscotec

Market Cap: ₩1.2t

Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.

AprilBioLtd

Market Cap: ₩474.2b

AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics.

Cohance Lifesciences

Market Cap: ₹338.5b

Cohance Lifesciences Limited engage in the end-to-end contract development and manufacturing of intermediates and active pharmaceutical ingredients in India.

Bonesupport Holding

Market Cap: SEK 19.5b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

PharmaEssentia

Market Cap: NT$163.5b

A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.

Cantourage Group

Market Cap: €51.0m

Operates as a medical cannabis company in Europe.

argenx

Market Cap: €34.6b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

Jiangsu Sinopep-Allsino Biopharmaceutical

Market Cap: CN¥14.2b

A biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China.

Wedge IndustrialLtd

Market Cap: CN¥8.2b

Engages in the research and development, production, and sale of micro-ecological live bacteria products, superalloys, and related products in China.

Xiamen Amoytop Biotech

Market Cap: CN¥34.7b

Engages in research, development, production, and sale of recombinant protein drugs in China.

Jeena Sikho Lifecare

Market Cap: ₹89.5b

Trades in ayurvedic medicines in India.

Newron Pharmaceuticals

Market Cap: CHF 152.3m

A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.

Alvotech

Market Cap: US$2.6b

Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.

WuXi XDC Cayman

Market Cap: HK$69.5b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

Acutaas Chemicals

Market Cap: ₹116.6b

Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E)

Market Cap: ج.م6.3b

Produces and sells a range of branded generic pharmaceuticals, food supplements, veterinary products, and nutraceuticals in Egypt.

SKAN Group

Market Cap: CHF 1.5b

Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.

ADMA Biologics

Market Cap: US$4.2b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Corcept Therapeutics

Market Cap: US$7.4b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

ACADIA Pharmaceuticals

Market Cap: US$4.3b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

PharmaResources (Shanghai)

Market Cap: CN¥5.4b

Operates as a CRO, CDMO, and CMO service provider of drug discovery in China.

Nicox

Market Cap: €26.5m

Operates as an ophthalmology company in France and internationally.

Hualan Biological Vaccine

Market Cap: CN¥11.1b

Engages in the research, development, production, and sale of vaccines in China.

Zhejiang Jolly PharmaceuticalLTD

Market Cap: CN¥13.8b

Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.

Abeona Therapeutics

Market Cap: US$370.7m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

Boji Medical TechnologyLtd

Market Cap: CN¥4.4b

Provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally.

Kexing Biopharm

Market Cap: CN¥8.9b

Engages in the research and development, production, and sale of recombinant protein drugs and microbial preparations in China and internationally.

Aether Industries

Market Cap: ₹102.3b

Produces and sells advanced intermediates and specialty chemicals in India and internationally.

Concord Biotech

Market Cap: ₹184.9b

A biopharma company, engages in the research and development, manufacture, market, and sale of pharmaceutical products in India and internationally.

Oncodesign Precision Medicine Société anonyme

Market Cap: €6.9m

A biopharmaceutical company, engages in the precision medicine business.

CorMedix

Market Cap: US$1.0b

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Innova Captab

Market Cap: ₹52.2b

An integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally.

Orchid Pharma

Market Cap: ₹39.2b

A pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India.